A A A      Català |  Castellano |  English
 
logo

grups de recerca:

Neurogenètica i Epidemiologia de les Patologies Ansioses

Responsable: Dr. A. Bulbena Vilarrasa
Seu:
Institut d'Atenció Psiquiàtrica: Salut Mental i Toxicomanies
Edifici Hospital del Mar
Passeig Marítim, 25-29
08003 Ciutat Vella
Barcelona
Tel. +34 932483175 / Fax +34 932483445
email: abulbena@acmcb.es
Components:
    - Antonio Bulbena Vilarrasa
    - Marta Torrens Mèlich
    - Luis Miguel Martín López
    - Carles García-Ribera Comdor
    - Belén Díaz Múgica
    - Salvador Ros Montalbán
    - Guillem Pailhez Vindual
    - Jaume Fatjó Rios
    - Paula Calvo Soler
Línies de recerca:
- Estudis dels recursos assistencials a poblacions marginals i dels recursos en situacions d'emergència.
- Neuroimatge de les crisis ansioses en les esquizofrènies.
- Estudis de neuroimatge estructural i funcional en el Trastorn per dèficit d'atenció amb hiperactivitat.
- Salut Mental i animals de companyia.
Projectes:
Publicacions:

Fullana MA, Cardoner N, Alonso P, Subirà M, López-Solà C, Pujol J, Segalàs C, Real E, Bossa M, Zacur E, Martínez-Zalacaín I, Bulbena A, Menchón JM, Olmos S, Soriano-Mas C. Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: a morphometric study. Psychol Med. 2013 Jun 18:1-12. [Epub ahead of print]

Burón E, Bulbena A, Barrada JR, Pailhez G. EROL scale: a new behavioural olfactory measure and its relationship with anxiety and depression symptoms. Actas Esp Psiquiatr. 2013 Jan-Feb;41(1):2-9. Epub 2013 Jan 1.

Burón E, Bulbena A. Olfaction in affective and anxiety disorders: a review of the literature. Psychopathology. 2013;46(2):63-74. doi: 10.1159/000338717. Epub 2012 Aug 7. Review.

Tribó MJ, Rozas-Muñoz EA, Gallardo F, Casanova N, Ros-Montalban S, Bulbena A, Pujol R. Zonisamide for the treatment of self-inflicted dermatoses related to impulse control disorders. Arch Dermatol. 2012 Jun;148(6):762-4. doi: 10.1001/archdermatol.2011.3620.

Torrens M, Rossi PC, Martinez-Riera R, Martinez-Sanvisens D, Bulbena A. Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system? Subst Use Misuse. 2012 Jun-Jul;47(8-9):1005-14. doi: 10.3109/10826084.2012.663296. Review.

Alvarez P, Puente VM, Blasco MJ, Salgado P, Merino A, Bulbena A. Concurrent Koro and Cotard syndromes in a Spanish male patient with a psychotic depression and cerebrovascular disease. Psychopathology. 2012;45(2):126-9. doi: 10.1159/000329739. Epub 2012 Feb 4.

Burón E, Bulbena A, Pailhez G, Bulbena Cabré A. [The Spanish version of two olfactory scales: reliability and validity]. Rev Psiquiatr Salud Ment. 2011 Oct;4(4):187-94. doi: 10.1016/j.rpsm.2011.07.006. Epub 2011 Nov 8. Spanish.

Mendoza L, Navinés R, Crippa JA, Fagundo AB, Gutierrez F, Nardi AE, Bulbena A, Valdés M, Martín-Santos R. Depersonalization and personality in panic disorder. Compr Psychiatry. 2011 Jul-Aug;52(4):413-9. doi: 10.1016/j.comppsych.2010.09.002. Epub 2010 Nov 5.

Remvig L, Engelbert RH, Berglund B, Bulbena A, Byers PH, Grahame R, Juul-Kristensen B, Lindgren KA, Uitto J, Wekre LL. Need for a consensus on the methods by which to measure joint mobility and the definition of norms for hypermobility that reflect age, gender and ethnic-dependent variation: is revision of criteria for joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type indicated? Rheumatology (Oxford). 2011 Jun;50(6):1169-71. doi: 10.1093/rheumatology/ker140. Epub 2011 Apr 10. No abstract available.

Pailhez G, Rosado S, Bulbena Cabré A, Bulbena A. Joint hypermobility, fears, and chocolate consumption. J Nerv Ment Dis. 2011 Nov;199(11):903-6.

Bulbena A, Gago J, Pailhez G, Sperry L, Fullana MA, Vilarroya O. Joint hypermobility syndrome is a risk factor trait for anxiety disorders: a 15-year follow-up cohort study. Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):363-70. Epub 2011 Apr 27.

Guillén V, Santos B, Yllá L, Bulbena A, Bilbao J, Fernández E, de Lazarraga IP, González-Pinto AM, González-Pinto A. Depressive dimensions and item response analysis of the Hamilton Depression Rating Scale-17 in eating disorders. Compr Psychiatry. 2011 Jul 6. [Epub ahead of print]

Martín-López LM, Rojo JE, Gibert K, Martín JC, Sperry L, Duñó L, Bulbena A, Vallejo J. The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients. Depress Res Treat. 2011;2011:140194. Epub 2011 Jun 15.

García-Ribera C, Bulbena A. Determinants of medicine-taking in psychiatric patients. Curr Clin Pharmacol. 2011 May;6(2):100-7. Review.

Fullana MA, Fernández de la Cruz L, Bulbena A, Toro J. [Efficacy of cognitive-behavior therapy for mental disorders.] Med Clin (Barc). 2011 Apr 25. [Epub ahead of print] Spanish. No abstract available.

Fullana MA, Vilagut G, Ortega N, Bruffaerts R, de Girolamo G, de Graaf R, Haro JM, Kovess V, Matschinger H, Bulbena A, Alonso J. Prevalence and correlates of respiratory and non-respiratory panic attacks in the general population. J Affect Disord. 2011 Jun;131(1-3):330-8. Epub 2010 Dec 22.

Malagón A, Alvaro P, Córcoles D, Martín-López LM, Bulbena A. 'Hikikomori': a new diagnosis or a syndrome associated with a psychiatric diagnosis? Int J Soc Psychiatry. 2010 Sep;56(5):558-9. No abstract available.

Pailhez G, Bulbena A, López C, Balon R. Views of psychiatry: a comparison between medical students from Barcelona and Medellin. Acad Psychiatry. 2010 Jan-Feb;34(1):61-6. No abstract available.

Pailhez G, Meroño O, Agulló A, Bulbena A. [Relation between blood pressure and joint hypermobility]. Med Clin (Barc). 2011 Apr 23;136(11):505-6. Epub 2009 Dec 30. Spanish. No abstract available.


[<] Tornar


     Departament of Psychiatry and Forensic Medicine | School of Medicine | UAB Campus | 08193
     Bellaterra (Cerdanyola del Vallès) Spain | t. +34 935812381 / +34 935811225 | f. +34 935811435